Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice

  1. Álamo, M.C.
  2. Ochenduszko, S.
  3. Crespo, G.
  4. Corral, M.
  5. Oramas, J.
  6. Sancho, P.
  7. Medina, J.
  8. Garicano, F.
  9. López, P.
  10. Balea, B.C.
  11. Garzotto, A.R.
  12. Muñoz-Couselo, E.
Revue:
OncoTargets and Therapy

ISSN: 1178-6930

Année de publication: 2021

Volumen: 14

Pages: 5345-5352

Type: Article

DOI: 10.2147/OTT.S325208 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus